Heron Therapeutics, Inc. (HRTX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Heron Therapeutics, Inc. on December 23, 2024. The report discloses a material corporate event regarding the relocation of the company's principal executive offices.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a corporate event and does not contain financial statements or performance metrics.
Material Changes
- Headquarters Relocation: The company announced the relocation of its corporate headquarters from San Diego, California, to Cary, North Carolina.
- New Address: 100 Regency Forest Drive, Suite 300, Cary, NC 27518.
- Former Address: 4242 Campus Point Court, Suite 200, San Diego, CA, 92121.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future performance, or specific risk factors related to the relocation. The press release detailing the move is attached as Exhibit 99.1 but is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the operational impact and timeline of the headquarters move from San Diego to Cary.
- Review the attached press release (Exhibit 99.1) for details on the strategic rationale for the relocation.
- Monitor future filings for any cost implications or lease termination fees associated with the San Diego office.
- Confirm the company's continued listing status on The Nasdaq Capital Market under the symbol HRTX.